Bruce Holland: Ex Vivo Assessment of ActiGraft Clot Formation Under Anticoagulation
Bruce Holland, Independent Sales Representative at Legacy Medical Consultants, shared RedDress Medical’s post on LinkedIn:
“An important practical question for clinicians: how might stable clot formation under therapeutic anticoagulation affect confidence in considering ActiGraft for appropriate patients?
I’d be interested to hear how wound-care teams are thinking about this evidence.”
RedDress Medical shared a post on LinkedIn about a recent article by Barry Frank Jacobson et al, published in Journal of Thrombosis and Thrombolysis, adding:
“For a technology built on coagulation, demonstrating complete, stable clot formation under therapeutic anticoagulation is a clinically meaningful finding.
In a peer-reviewed ex vivo study, ActiGraft consistently formed complete, stable clots using blood from patients receiving warfarin or rivaroxaban.
More evidence.
More practical answers.
More confidence in where ActiGraft can be used.”
Title: Autologous whole blood clot formation with actigraft in patients receiving oral anticoagulant therapy: an ex vivo feasibility study
Authors: Barry Frank Jacobson, Elise Schapkaitz, Melanie Mc Cree
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 24, 2026, 15:09Caroline Voltz-Girolt: Accelerating the Development of Innovative Therapies for Rare Blood Disorders
-
Sep 24, 2026, 15:00Gambo Ramatu: Anemia as a Preventable Pregnancy Challenge
-
Sep 24, 2026, 14:56Holly John: Sickle Cell Disease Beyond Pain and Clinical Outcomes
-
Sep 24, 2026, 14:33Mohamed El Belghiti Alaoui: Thrombin as a Therapeutic Target in Coagulation
-
Sep 24, 2026, 14:22Integrating Thrombosis Risk Into Menopause Care – World Thrombosis Day
-
Sep 24, 2026, 13:41Mahmoud Samir Bayomi: Raise ITP Awareness and Improve Patient Care
-
Sep 24, 2026, 12:56Maria Helena Parrinello: A New Score for Chronic GvHD Risk Assessment at the SIE Congress
-
Sep 24, 2026, 12:44Shehab Mohamed: TP53 Mutations and Outcomes in Myeloproliferative Neoplasms
-
Sep 24, 2026, 12:34Francesca Palandri: Is There Still a Place for Splenectomy in ITP in the Modern Era?